cancer research jobs glasgow

Together we are beating cancer

About cancer

Cancer types

• Breast cancer
• Bowel cancer
• Lung cancer
• Prostate cancer

Cancers in general

• Clinical trials

Causes of cancer

Coping with cancer

• Managing symptoms and side effects
• Mental health and cancer
• Money and travel
• Death and dying
• Cancer Chat forum

Health Professionals

• Cancer Statistics
• Cancer Screening
• Learning and Support
• NICE suspected cancer referral guidelines

Get involved

• Make a donation

By cancer type

• Leave a legacy gift
• Donate in Memory

Find an event

• Race for Life
• Charity runs
• Charity walks
• Search events
• Relay For Life
• Volunteer in our shops
• Help at an event
• Help us raise money
• Campaign for us

Do your own fundraising

• Fundraising ideas
• Get a fundraising pack
• Return fundraising money
• Fundraise by cancer type
• Set up a Cancer Research UK Giving Page
• Find a shop or superstore
• Become a partner
• Cancer Research UK for Children & Young People
• Our We Are campaign

Our research

• Brain tumours
• Skin cancer
• All cancer types

By cancer topic

• New treatments
• Cancer biology
• Cancer drugs
• All cancer subjects
• All locations

By Researcher

• Professor Duncan Baird
• Professor Fran Balkwill
• Professor Andrew Biankin
• See all researchers
• Our achievements timeline
• Our research strategy
• Involving animals in research

Funding for researchers

Research opportunities

• For discovery researchers
• For clinical researchers
• For population researchers
• In drug discovery & development
• In early detection & diagnosis
• For students & postdocs

Our funding schemes

• Career Development Fellowship
• Discovery Programme Awards
• Clinical Trial Award
• Biology to Prevention Award
• View all schemes and deadlines

Applying for funding

• Start your application online
• How to make a successful application
• Funding committees
• Successful applicant case studies

How we deliver research

• Our research infrastructure
• Events and conferences
• Our research partnerships
• Facts & figures about our funding
• Develop your research career
• Recently funded awards
• Manage your research grant
• Notify us of new publications

Find a shop

• Volunteer in a shop
• Donate goods to a shop
• Our superstores

Shop online

• Wedding favours
• Cancer Care
• Flower Shop

Our eBay store

• Shoes and boots
• Bags and purses
• We beat cancer
• We fundraise
• We develop policy
• Our global role

Our organisation

• Our strategy
• Our Trustees
• CEO and Executive Board
• How we spend your money
• Early careers

Cancer news

• Cancer News
• For Researchers
• For Supporters
• Press office
• Publications
• Update your contact preferences

ABOUT CANCER

GET INVOLVED

NEWS & RESOURCES

FUNDING & RESEARCH

You are here

Careers at Cancer Research UK

Content not working due to cookie settings.

Join a team of over 4,000 people from a diverse range of backgrounds and help create a world where people can live longer, better lives, free from the fear of cancer. Find a purposeful career that will empower you to grow and collaborate with like-minded experts. Together, we are beating cancer.

View current vacancies

Be part of an inclusive charity

Our vision is to create a diverse charity where everyone feels they belong and benefits from the work we do. We value different perspectives that could help us find innovative solutions to our challenges and we want a workforce that represents our communities. We’re committed to funding research into cancer inequalities, diversifying our research community and developing an inclusive culture for all staff. This is how we’ll beat cancer for everyone. 

Find out more

Find your team

Our specialist teams and departments are structured across six directorates. All of our teams play an important role in supporting our mission. 

Chief Operating Office The Chief Operating Office brings together four exceptions departments under one function - HR, Finance, General Counsel and Technology.

Marketing, Fundraising and Engagement The people in our Marketing, Fundraising and Engagement teams are essential to engaging with the UK public in deep and meaningful ways, ultimately growing our fundraising.

Philanthropy The Philanthropy team help the charity to engage with the biggest philanthropists and partners from across the world to build transformative new approaches to cancer reserch.

Policy, Information and Communications The Policy, Information and Communications directorate works to identify and reduce the barriers that are stopping new innovations in cancer prevention, diagnosis and care from being made available and used.

Research and Innovation Our Research and Innovation directorate aim to be the world's leading cancer research and innovation organisation.

Retail Our superstores, eCommerce operation and around 550 shops across the UK are a major source of our fundraising.

Strategy The Strategy team leads on the charity’s corporate strategy. They work with more than 120 partners and philanthropists in the UK and around the world. 

Learn more about our different teams

Launch your charity career

Whether you’re a student, a graduate or you’re looking to change careers, we have paid programmes that'll help you learn and develop your skills. Make your professional life one that matters.

Explore early careers opportunities

Explore our staff benefits

We want to develop and sustain a working environment that supports the wellbeing of our people, providing support options to enable everyone to bring their best possible selves to work. We believe that having compassion at the very foundation of who we are, paired with the right practical support, will create a better performing charity and give us the best chance to beat cancer. 

Discover our staff benefits

Connect with our values

Our values represent who we are and will help us to bring our best to what we do and ensure Cancer Research UK is a great place to work. 

Bold: Act with ambition, courage and determination

Credible: Act with rigour and professionalism 

Human: Act to have a positive impact on people 

Together: Act inclusively and collaboratively  

View all open opportunities

It’s an absolutely fabulous place to work. You come here, and you go "wow, there's so many people". I think the myth is that we're too big to care. We're not, I think it's a really positive, inclusive and supportive place to work.

Leila McCallum, Chief Operating Office

Join a workplace that encourages collaboration

We encourage a flexible working culture, including options such as home-working, reduced or flexi-hours, job shares, job-splits, compressed and core hours. We also offer a high level of flexibility for the vast majority of our office-based roles, meaning that you’ll only be required to work from a specific location for one or two days a week on average.  

Cancer Research UK 

2 Redman Place, London, E20 1JQ 

PO BOX 1561 

Oxford, OX4 9GZ 

Work in one of our shops, superstores and warehouses across the UK

Cancer Research UK Scotland Institute, Glasgow 

Switchback Rd, Bearsden, 

Glasgow, G61 1BD

Babraham Research Campus, Cambridge

Babraham Hall, Babraham,

Cambridge, CB22 3AT

The Francis Crick Institute, London 

1 Midland Road,

London, NW1 1AT

View current opportunities

Already applied?

We’ll keep you updated on your application by email and let you know about anything you’ll need to prepare if you’re shortlisted. We receive a large volume of applications so this may take a few days after the closing date, please be patient with us. 

You can also log in to your online account at any time to check the status of your application by visiting our vacancies website. 

You might also be interested in

Volunteering.

There are lots of ways you can involved and support our pioneering work. If a paid job for us isn’t right for you just now, why not volunteer with us instead?

Our Strategy

We exist to beat cancer. Our focus is making discoveries, driving progress and bringing hope to people affected by cancer.

Our specialist recruitment teams are here to support you if you have any questions or should you require any adjustment due to a disability or a long-term health condition.

• Skip to main menu
• Skip to user menu

This job has expired

Postdoctoral Research Scientist

Beatson lab: Cell Plasticity & Epigenetics

PI name: Maximiliano Portal

Project Title:  Unravelling the molecular phylo(epi-)genetic code underlying cell plasticity in cancer and beyond.

Salary:  from £32,868 to £42,717 subject to experience, plus relocation allowance and visa costs if required.

Contract term:  Fixed up to 6 years, subject to successful review at Year 3

The CRUK Scotland Institute is a world leading cancer research centre located in the vibrant city of Glasgow, Scotland, which counts with numerous state-of-the-art facilities encompassing the development of basic and translational research programmes. Situated in the open parkland in the Garscube campus, we provide a dynamic environment where researchers can further develop both their scientific research and their careers whilst nested in a highly collaborative and supportive environment.

Project outline

Increasing evidence suggest that the non-genetic compartment harbours equal relevance than the genome to define life as we know it and should not be neglected when assessing biological phenomena. The goal of our lab is to contribute to the understanding of the mechanisms underlying non-genetically encoded cell plasticity – the capability to finely tune phenotypic output without altering the genetic compartment – supporting the adaptation and evolution of individual cells in a variety of biological settings including – but not limited to – malignant transformation and therapeutic challenge.

The aim of our lab has evolved into a blend of basic biology research with a technological counterpart encompassing the development of multimodal single cell technologies that allow us to query the underpinnings of transcriptome plasticity with previously unseen molecular detail. Supported by our technologies we discovered that transcriptome heterogeneity in isogenic cell populations is not the result of stochastic events but is dictated by the molecular plasticity of each cell which is linked to its phylo-epi-genetic lineage. We found that this constrained molecular plasticity determines the phenotypic output of each cell in response to cytokines, during EMT/MET and notably throughout malignant transformation.

In a nutshell, the queries at the core of our research programme are:

• How plastic a cellular system can be? Is cell plasticity encoded in molecular devices other than DNA? And if so… Is there a “read-write” code? What is the role of cell plasticity in cancer onset and evolution?

We are looking for an enthusiastic, motivated and curious individual, that has or soon will be completing a PhD in a relevant subject to move forward our research programme. Experience in molecular biology, single-cell and/or spatial technologies, cancer genomics and/or epigenetics are desirable but not essential. All areas of biology are most welcome.

For informal enquiries, please email [email protected] . More details regarding the research can be found on the application website. 

Postdoc support

Postdocs are key members of our research community, and we offer them a range of opportunities to train and develop as researchers while they are with us:

• Exciting, innovative cancer research projects in state-of-the art labs A highly collaborative and interactive research environment Access to and training in key advanced technologies. A mentor enabling scheme to aid personal and professional development. A rich programme of scientific exchange through seminars, workshops and meetings Support for preparing fellowship and small grant applications, including during their transition to their next position. Guidance and mentoring to compete for an independent scientist position as well as a multitude of other career options, including in industry. A highly engaged postdoc forum, providing peer support, training, careers advice and regular social events

Equality, Diversity and Inclusion

Our overarching research ethos at the Institute is about excellence, honesty, openness, accountability and integrity. The diversity of our staff and students is also what makes the Institute such a vibrant place to work and advance discoveries in cancer research. Family friendly policies, our collaborative ethos, a focus on good mental health and well-being and opportunities for all help to create an enjoyable and inclusive workplace where your voice matters.

The Institute is also committed to increasing the number of female scientists at the postdoc level and beyond and encourages female applicants to apply. We have recently introduced a highly attractive maternity policy which provides 12-18 months support and funding for postdocs wishing to take time off to spend with their children amongst other family friendly policies .

Employee Benefits

• Competitive salary
• 40.5 days annual leave including bank holidays (pro-rata)
• Defined Contribution pension scheme
• Life Insurance scheme
• Employee Assistance Programme
• Season ticket loan
• Additional maternity pay at 6 month’s full pay (subject to service)
• Shared parental leave
• Cycle to work scheme that could save you 26-40% on a bike and accessories.
• Access to Employee benefit schemes with discounts on supermarkets, cinema, travel and much more.
• On-site secure parking

All applications must be made via our website at http://www.beatson.gla.ac.uk/careers/postdoctoral-fellows/

Closing Date:   3 rd November 2023 . We will contact promising candidates on a rolling basis, so please apply as soon as you are ready.

Share this job

Get job alerts

Create a job alert and receive personalised job recommendations straight to your inbox.

• Skip to main content

We use cookies

Necessary cookies.

Necessary cookies enable core functionality. The website cannot function properly without these cookies, and can only be disabled by changing your browser preferences.

Analytics cookies

Analytical cookies help us improve our website. We use Google Analytics. All data is anonymised.

Clarity helps us to understand our users’ behaviour by visually representing their clicks, taps and scrolling. All data is anonymised.

Privacy policy

Cancer research at Glasgow

• 1: Introduction
• Executive summary
• 2: Cancer sciences in Glasgow
• 3: The impact of the CRUK Scotland Institute’s and the School of Cancer Sciences’ expenditures
• 4: The impact of the CRUK Scotland Institute’s and the School of Cancer Sciences’ research
• 5: The impact of teaching and learning activities
• 6: Total economic impact of the CRUK Scotland Institute and School of Cancer Sciences

1.1 Background

London Economics were commissioned to assess the economic impact of the Cancer Research UK Scotland Institute (formerly Beatson Institute) and the University of Glasgow’s School of Cancer Sciences (SCS) in the United Kingdom , incorporating an assessment of their contribution to the UK’s national prosperity through their wide-ranging cancer research activities , their operating and capital expenditures , and their teaching and learning activities . Working in close collaboration, the CRUK Scotland Institute and the University of Glasgow constitute the core cancer research institutions in the West of Scotland. This work builds on our previous analysis of the economic impact of the University of Glasgow as a whole (London Economics, 2021), and focuses on the 2021-22 financial year. 9

For over a century, cancer sciences have been a significant part of the fabric of Glasgow’s research ecosystem. From the establishment of the Glasgow Cancer and Skin Hospital in 1886 until the present day, Glasgow has been at the heart of the global effort to further our understanding of cancer, developing new ideas, techniques, and practices and delivering benefits to patients across Scotland and beyond. The contribution of these advances to our collective understanding of cancer has led to improvements in the identification and treatment of the disease and declining cancer mortality rates. However, despite this progress, cancer remains the largest burden of disease across Scotland, and incidence rates have continued to increase over time. In 2021, there were over 35,000 new cancer diagnoses registered in Scotland (Public Health Scotland, 2023), and this is projected to increase in the future as the country’s population ages. This is a particular issue for the West of Scotland, with Greater Glasgow and Clyde exhibiting the highest cancer incidence of any health board in Scotland in 2021, with 702 cancers 10 per 100,000 residents (see Figure 1).

Studies also show that the burden of cancer is not the same for all groups in society. Data referenced in the Scottish Government’s 2023 Cancer Strategy (Scottish Government, 2023) highlights the disproportionate impact of socioeconomic deprivation on cancer incidence and survival rates. The data shows that a person living in the most deprived areas of Scotland is 30% more likely to develop cancer than someone living in the least deprived areas, and 74% more likely to die from cancer compared with the least deprived. Scotland also has a relatively unique geography, as it encompasses large urban centres, rural areas, and island communities. As the Scottish Government’s strategy highlights, this poses additional challenges for Scotland in ensuring that patients across the country benefit equitably from advancements in the diagnosis and treatment of cancer.

Figure 3 Cancer incidence in Scotland by Scottish Health Board, in 2021

Note: Cancer incidence refers to the European age-standardised rate for all cancers excluding non-melanoma skin cancer.

Source: London Economics’ analysis based on Public Health Scotland (2023) data. Copyright Scottish Government, contains Ordnance Survey data © Crown copyright and database right (2023).

This diversity of need and diversity of patient base has resulted in an emergence of different strengths in cancer sciences across Scotland’s regions. This is reflected in the development of different research specialisms across Scotland’s world-class universities, such as remote and rural medicine, drug discovery and precision medicine, and the use of artificial intelligence (AI) and other technologies. Glasgow serves as a key example of the benefits of the development of different cancer research specialisms that derive from local needs, challenges, and strengths.

As Scotland’s largest city, Glasgow and the surrounding areas in the West of Scotland account for a patient base of around 2.8 million patients (Invest Scotland, 2023), which represents more than half of the Scottish population. The city is home to the largest health board in Scotland and the largest cancer centre – the Beatson West of Scotland Cancer Centre – which sees more than 8,500 new patients and over 60,000 return patients every year (Beatson West of Scotland Cancer Centre, 2023). The size of the patient base in the region serves as an ideal location from which to undertake clinical trials and test prevention strategies for cancer and other chronic diseases.

As well as its size, the health needs and prevalence of disease within the region’s population base are complex, with longstanding health disparities and comparatively high incidence of chronic diseases. Glasgow’s industrial heritage has also left a mark in terms of the prevalence of certain types of cancer within the region. The West of Scotland has some of the highest incidence rates of malignant mesothelioma in the world, due to the previous   widespread use of asbestos in key industrial sectors such as shipbuilding. Unfortunately, current treatment options are limited, and those diagnosed with malignant mesothelioma have very poor survival rates. Academics and clinicians in Glasgow have been central to efforts to change this situation and play a leading role in several national and international networks and projects aimed at developing more effective treatment options. For example, Glasgow’s REMIT programme, which builds on the University‘s PREDICT-Meso & IAMMED-Meso projects, is seeking to develop a comprehensive strategy for early detection, risk stratification and more effective treatments for mesothelioma patients, and received a portion of £2.1 million of funding from Cancer Research UK in March 2023. This serves as a key example of how a particular need has spawned world-leading academic and clinical expertise that is rooted in the West of Scotland.

The patient base in the West of Scotland is also differentiated by its high level of engagement with local cancer research initiatives. Research groups from the University of Glasgow’s School of Cancer Sciences and the CRUK Scotland Institute are well-integrated within the region’s hospitals and with local patient groups, thus supporting the rapid translation of scientific research into clinical settings. Local residents have also provided generous donations to cancer sciences research, to ensure that the legacy of this work continues to benefit the city’s residents, for example through the Beatson Pebble Appeal which generated £10M in public donations to build the University’s Wolfson Wohl Cancer Research Centre. This level of engagement has served as a key differentiator of the region’s approach to cancer sciences and plays an important role in attracting some of the world’s leading cancer researchers to work in Glasgow.

As this report highlights, Glasgow’s strengths in, and approach to, cancer sciences provide a range of benefits to the region’s economy. Healthcare and precision medicine were highlighted in the Glasgow City Region Economic Strategy (Glasgow City Region, 2021) as core areas of comparative advantage for the region, with strong potential for future growth through the use of advanced technology within healthcare. This was further exemplified by the awarding of Levelling Up Innovation Accelerator funding to a bowel cancer screening and risk stratification tool, highlighting the potential for the region’s expertise in cancer sciences to further accelerate its flourishing innovation economy. Moreover, a number of major MedTech, pharmaceutical and healthcare companies have based themselves within the region to better integrate with the thriving life sciences ecosystem built within the Glasgow Riverside Innovation District.

Cancer remains one of the biggest health challenges facing Scotland, and the evidence suggests that this will remain the case in the future. However, Scotland’s leading role in life sciences and health innovation provides hope that this is a challenge that can be tackled collectively. This is signalled by the willingness of major players in this sphere to collaborate to drive benefits for patients. The University of Glasgow, for example, works closely with the NHS and its major industry partners, such as GE Healthcare, on innovative, people-centred solutions to improve healthcare treatment and outcomes. This approach is in evidence across different parts of the country, which have developed expertise and specialisms that reflect the particular needs of, and challenges faced by, local patient bases. As the West of Scotland's core cancer research institutions, together, the CRUK Scotland Institute and the SCS constitute two key drivers of Scotland’s leadership in cancer sciences.

The CRUK Scotland Institute’s financial year 2021-22 ran from April 2021 to March 2022. The School of Cancer Sciences’ financial year matches the University of Glasgow’s academic year (August to July), but data for the School of Cancer Sciences was apportioned across the 2020-21 and 2021-22 academic years for consistency, to match the CRUK Scotland n Institute’s financial year.

Using the European age-standardised rate for all cancers excluding non-melanoma skin cancer.

1.2 Structure of this report

1.2 structure of this report .

The remainder of this report is structured as follows:

In Section 2 , we provide further background on Glasgow’s cancer sciences ecosystem, and the many ways in which the CRUK Scotland Institute and the SCS have been working together to support and use the West of Scotland’s cancer sciences infrastructure;

In Section 3 , we outline our assessment of the impact of the institutions’ operating and capital expenditures;

In Section 4 , we discuss our findings on the impact of the CRUK Scotland Institute’s and the SCS’s research activities;

In Section 5 , we assess the economic impact associated with the institutions’ teaching and learning activities for postgraduate research students who are taught at the SCS and the CRUK Scotland Institute; and

In Section 6 , we combine these different strands of impact to analyse the total economic impact associated with the CRUK Scotland Institute and the SCS. 

How We Help

We're with you.

• Wellbeing Services
• Health & Work Service
• Helpful Resources
• Group Support
• Bereavement Support
• Get Involved

Working For Us

Current vacancies.

See our latest vacancies on offer

Keep an eye out for vacancies!

Beatson Cancer Charity supports people affected by cancer, every step of the way. We aim to achieve this through our dedicated staff team, working behind the scenes and directly with people living with cancer throughout their journey.   

By joining Team Beatson you will become part of a committed team of individuals making a difference to those affected by cancer.  

Departments

Beatson Cancer Charity have a whole range of departments which collectively all play a part for the cause. With a large network of dedicated professionals, we are able to make a meaningful impact on the lives of those affected by cancer.

Our Departments

Meet the individuals who make up our different departments.

Wellbeing & Admin

Finance & Corporate Services

Fundraising

Human Resources

Individual Giving & Support Care

Marketing Communications

Outreach Services

Philanthropy

Volunteering

Senior Leadership Team

What to expect from us.

An induction that will welcome you into the Charity and give you a great foundation to understanding our values and behaviours. This will include meeting each department to understand their objectives, how your role links into the departments and embed you into Team Beatson. Find out about some of the perks of being a part of Team Beatson from our mascot Bella Beatson!

If you would like to learn more about our current employment opportunities or have any questions, please do not hesitate to reach out to us at ' [email protected] '. We would be delighted to help you with anything you need.

Request a fundraising pack

Fundraising Materials

Annual Review 2022/23

Annual Review 22-23

Our ambassadors

Find out more

Registered Office/Head Office: Beatson Cancer Charity, The Beatson West of Scotland Cancer Centre, 1053 Great Western Road, Glasgow, G12 0YN,

Tel: 0141 212 0505 | Company No. SC461242 (Scotland Charity No. SC044442) | VAT No. 274839460 | Registered at Companies House, Edinburgh

• Accessibility
• Privacy Policy
• Copyright & Disclaimer
• Cookie Policy

Website by Equator

This website uses cookies to ensure you get the best experience on our website

• Our Partners
• Our Patient & Public Involvement
• Colorectal Cancer Theme
• Hepatobiliary Cancer Theme
• Mesothelioma Theme
• Pancreatic Cancer Theme
• Brain Tumours Theme
• Gynaecological Cancer Theme
• TRACC Programme MB-PhD or BDS-PhD
• TRACC Programme CRTF-PhD
• Research Training Environment
• Notable Outcomes & Events
• TRACC Programme Management Board
• Ryan Devlin
• Tian En Lim
• Mairi Treanor-Taylor
• Lorna Stillie
• Douglas Cartwright
• Michael Gillespie
• Projects & Supervisors
• Other useful information
• Current PhD students

We are the cancer research centre for Scotland

The Cancer Research UK Scotland Centre aims to translate the latest discovery science into patient benefit. It is funded by Cancer Research UK and is a partnership between the Universities of Edinburgh and Glasgow, MRC Human Genetics Unit, Cancer Research UK Scotland Institute, NHS Lothian, NHS Greater Glasgow and Clyde.

A Cancer Research Centre For People In Scotland

Read more about our scientists and clinicians and the work they are doing as part of our Centre teams.

Learn more about our research

Find out more about the infrastructure, resources and funding available to support researchers across the Centre.

Learn more about our resources

• Edinburgh Cancer Research
• CRUK Scotland Institute
• Scottish Genomes Partnership
• CRUK Centres
• ECMC Network
• Terms and Conditions
• Privacy Policy

Copyright © 2024 Cancer Research UK Scotland Centre. All rights reserved.

• CRUK Scotland Centre
• Cancer Research Horizons
• Board of Directors
• Equality, Diversity and Inclusion (EDI) Statement
• Gender Pay Gap 2023
• Research Integrity Annual Statement 2023
• Use of Animals in Our Research
• Scientific Advisory Board
• Sources of Funding
• Annie McNab Bequest
• Commercial Partnerships
• Annual Report
• Public Transport
• Travelling by Car
• Imran Ahmad - Models of Advanced Prostate Cancer
• Tom Bird - Liver Cancer, Disease and Regeneration
• Karen Blyth - In Vivo Cancer Biology
• Dave Bryant – Epithelial Polarity
• Martin Bushell - RNA and Translational Control in Cancer
• Ross Cagan - Biology of Therapeutics
• Leo Carlin - Leukocyte Dynamics
• Seth Coffelt – Immune Cells and Metastasis
• Julia Cordero – Local and Systemic Functions of the Intestine in Health and Disease
• Vicky Cowling - Gene Regulation
• Zoi Diamantopoulou - Metastasis and circadian rhythm
• Fieke Froeling – Molecular Subtypes and the Host in Pancreatic Cancer
• Xiao Fu - Integrative Modelling
• Payam Gammage - Mitochondrial Oncogenetics
• Danny Huang - Ubiquitin Signalling
• Gareth Inman - Growth Factor Signalling and Squamous Cancers
• Kristina Kirschner - Stem Cell Ageing & Cancer
• John Le Quesne - Deep Phenotyping of Solid Tumours
• Hing Leung - Prostate Cancer Biology
• David Lewis - Molecular Imaging
• Tom MacVicar - Mitochondrial Reprogramming in Cancer
• Kendle Maslowski - Microbial and Metabolic Immune Modulation
• Crispin Miller - Computational Biology
• Jen Morton - Preclinical Pancreatic Cancer
• Daniel J Murphy - Oncogene-Induced Vulnerabilities
• Jim Norman - Integrin Cell Biology
• Maximiliano Portal - Cell Plasticity & Epigenetics
• Ed Roberts - Immune Priming and the Tumour Microenvironment
• Kevin Ryan - Tumour Cell Death
• Owen Sansom - Colorectal Cancer and Wnt Signalling
• Colin Steele - Advanced Colorectal Cancer
• Stephen Tait - Mitochondria and Cell Death
• Saverio Tardito - Oncometabolism
• Sara Zanivan - Tumour Microenvironment and Proteomics
• Understanding the biology of early disease in an array of human malignancies
• Understanding metabolic vulnerabilities in vivo
• Targeting translational control for cancer therapy
• Membrane trafficking – a key player in metastasis
• Understanding how metabolism influences tumour invasiveness and the microenvironment
• Reprogramming neutrophils to suppress metastasis and enable immunotherapy
• Laboratory Services
• Scientific Services
• Information Services
• School of Cancer Sciences
• Transgenic Models of Cancer
• Transgenic Technology
• Advanced Light Microscopy Equipment
• High-Content Analysis
• Flow Cytometry
• Translational Molecular Imaging
• Metabolomics
• Bioinformatics & Data Science
• Glasgow Cancer Seminar Series
• Beatson Conference 2024
• Scientific Programme
• Registration
• Abstracts, Short Talks and Poster Session
• Venue and Transport Information
• Sponsors and Support
• Group Leaders
• Staff Scientists/Service Managers
• University of Glasgow Postdoc Positions
• Postdoc Society
• Scientific Officers
• Computing and Bioinformatics
• Research Services
• Administration
• Information About Glasgow and Scotland
• Equality, Diversity and Inclusion
• Studentships
• John Paul Career Award
• TRACC Programme MB-PhD
• TRACC Programme CRTF-PhD
• Research Training Environment
• Notable Outcomes & Events
• TRACC Programme Management Board
• Fellows & Alumni
• Projects & Supervisors
• Other useful information
• Internships
• High School Students

Recent Publications

The CRUK Scotland Institute (formerly the CRUK Beatson Institute)* is core-funded by Cancer Research UK and provides a dynamic, supportive and well-resourced environment for its basic and translational scientists. Our mission is to understand the mechanisms that regulate cancer cell proliferation, survival and dissemination; to identify critical components of these pathways as targets for novel cancer therapies; and to help translate this knowledge to patient benefit. The Institute is located in a state-of-the-art research building in parkland on the north-western edge of Glasgow and has close ties to the University of Glasgow’s basic and clinical cancer research groups.

*In September 2023, Cancer Research UK announced it will be providing up to £123m as part of a 7-year commitment to the Institute. The funding will underpin long-term cutting-edge discovery research exploring how cancers develop, grow and spread, as well as how the immune system can be harnessed to combat the disease. In recognition of the success of the Institute as a national centre of excellence, and to enable wider global recognition, the facility - formerly known as the CRUK Beatson Institute - also has the new title of the CRUK Scotland Institute .  

Opportunities

What's Happening Now

See our most recent publications

Click here to see current job vacancies at the Scotland Institute

Latest News

• CRUK Scotland Institute partners with DEBRA UK to tackle early onset cancer in patients with RDEB
• Dr Fieke Froeling and Team SAMBAI receive £20m Cancer Grand Challenges award
• Publication Highlights: September & October 2023

Latest cancer news stories

• That Cancer Conversation podcast – Shaumya’s story
• Cancer vaccines could be game changing, but they’re not a one-shot solution to beating cancer
• More environmentally sustainable cancer research

The RSS feed originates from www.cancerresearchuk.org and we are not responsible for that RSS feed or its content and we do not accept liability in respect of your use or inability to use the RSS feed or its content.

The Beatson Institute for Cancer Research, a Registered Scottish Charity No SC006106 & Company Limited by Guarantee (Registered in Scotland No 84170) [trading as the Cancer Research UK Scotland Institute]

Get in Touch

call +44(0) 141 330 3953

[email protected]

Garscube Estate Switchback Road Bearsden Glasgow, G61 1BD

Follow us on Twitter @CRUK_SI

See our Wikipedia page